The use of scalp cooling for chemotherapy-induced hair loss
Abstract
Chemotherapy-induced hair loss is a common and distressing side effect of cancer therapy and is one of the major unmet challenges in cancer management. Scalp cooling can prevent chemotherapy-induced hair loss in some cancer patients with solid tumours receiving certain chemotherapy regimens. Recent evidence indicates that this technique does not increase the risk of scalp metastasis. A reduction in post-chemotherapy infusion duration of scalp cooling and the advancement in cool cap technology may assist clinicians in promoting scalp cooling to cancer patients. This article discusses recent research, scalp cooling guidelines, products available and implications for nurses and their organisations in providing scalp cooling. It also considers recent advancements in identifying genes associated with chemotherapy-induced hair loss and international research collaborations including a registry and a ‘chemotherapy-induced hair loss action group’–all striving to improve the patient experience of chemotherapy-induced hair loss.
References
- (2014) Use of in vitro human keratinocyte models to study the effect of cooling on chemotherapy drug-induced cytotoxicity. Toxicol In Vitro 28(8): 1366–76. doi: https://doi.org/10.1016/j.tiv.2014.07.011 Crossref, Medline, Google Scholar
- (2013) Efficacy and tolerability of two scalp cooling systems for the prevention of alopecia associated with docetaxel treatment. Support Care Cancer 21(9): 2565–73. doi: https://doi.org/10.1007/s00520-013-1804-9 Crossref, Medline, Google Scholar
- (2014) a-Melanocyte-stimulating hormone: a protective peptide against chemotherapy-induced hair follicle damage? Br J Dermatol 170(4): 956–60. doi: https://doi.org/10.1111/bjd.12759 Crossref, Medline, Google Scholar
- (2011) Presentation, impact and prevention of chemotherapy-induced hair loss: scalo cooling potentials and limitations Expert Review of Dermatology 6(1):109–25 Crossref, Google Scholar
Cancer Hair Care (2016) Cancer hair care. http://tinyurl.com/gp5fcu (accessed 16 May 2016 ) Google Scholar- (2014) Impact of chemotherapy-induced alopecia distress on body image, psychosocial well-being, and depression in breast cancer patients. Psychooncology 23(10): 1103–10. doi: https://doi.org/10.1002/pon.3531 Crossref, Medline, Google Scholar
- (2013) A genome-wide association study of chemotherapy-induced alopecia in breast cancer patients. Breast Cancer Res 15(5): R81. doi: https://doi.org/10.1186/bcr3475 Crossref, Medline, Google Scholar
- (2015) Efficacy of scalp cooling in preventing chemotherapy-induced alopecia in breast cancer patients receiving adjuvant docetaxel and cyclophosphamide chemotherapy. Clin Breast Cancer 15(5): 332–4. doi: https://doi.org/10.1016/j.clbc.2015.01.003 Crossref, Medline, Google Scholar
Royal Cornwall Hospitals NHS Trust (2015) Clinical guideline for the use of Scalp Cooling for Chemotherapy induced Alopecia. http://tinyurl.com/jttrefu (accessed 16 May 2016 ) Google Scholar- (2012) Looking good during cancer treatments. J Natl Cancer Inst 104(24): 1852–3. doi: https://doi.org/10.1093/jnci/djs516 Crossref, Medline, Google Scholar
- (2015) Core temperature affects scalp skin temperature during scalp cooling. Int J Dermatol 54(8): 916–21. doi: https://doi.org/10.1111/ijd.12568 Crossref, Medline, Google Scholar
- (2015) Prevention of alopecia in medical and interventional chemotherapy patients. J Cutan Med Surg 19(1): 11–6. doi: https://doi.org/10.2310/7750.2014.13200 Crossref, Medline, Google Scholar
- (2013) Determination of the most effective cooling temperature for the prevention of chemotherapy-induced alopecia. Mol Clin Oncol 1(6): 1065–71. doi: https://doi.org/10.3892/mco.2013.178 Medline, Google Scholar
Food and Drug Administration (2016) Medical devices; general and plastic surgery devices; classification of the scalp cooling system to reduce the likelihood of chemotherapy-induced alopecia. Final order. Fed Regist 81(29): 7452–4 Medline, Google ScholarFood and Drug Administration (2015) FDA allows marketing of cooling cap to reduce hair loss during chemotherapy. http://tinyurl.com/o9kynyn (accessed 18 May 2016 ) Google Scholar- (2014) Successful reduction of alopecia induced by anthracycline and taxane containing adjuvant chemotherapy in breast cancer—clinical evaluation of sensor-controlled scalp cooling. Springerplus 3: 500. doi: https://doi.org/10.1186/2193-1801-3-500 Crossref, Medline, Google Scholar
- (2013) Protection against chemotherapy-induced alopecia: targeting ATP-binding cassette transporters in the hair follicle? Trends Pharmacol Sci 34(11): 599–604. doi: https://doi.org/10.1016/j.tips.2013.09.001 Crossref, Medline, Google Scholar
- (2015) Psychological interventions for patients with cancer: psychological flexibility and the potential utility of Acceptance and Commitment Therapy. Eur J Cancer Care (Engl) 24(1): 15–27. doi: https://doi.org/10.1111/ecc.12223 Crossref, Medline, Google Scholar
- (2011) Breast cancer scalp metastasis as first metastatic site after scalp cooling: two cases of occurrence after 7- and 9-year follow-up. Breast Cancer Res Treat 128(2): 563–6. doi: https://doi.org/10.1007/s10549-011-1453-y Crossref, Medline, Google Scholar
- (2014) Survey about the use of scalp cooling to prevent alopecia during breast cancer chemotherapy treatment in Canada. Can Oncol Nurs J 24(2): 102–8. [Erratum appears in Can Oncol Nurs J 24(3):137] Medline, Google Scholar
- (2015) No effect of scalp cooling on survival among women with breast cancer. Breast Cancer Res Treat 149(1): 263–8. doi: https://doi.org/10.1007/s10549-014-3231-0 Crossref, Medline, Google Scholar
- (2008) The impact of cancer and chemotherapy: perceptual similarities and differences between cancer patients, nurses and physicians. Eur J Oncol Nurs 12(2): 97–102. doi: https://doi.org/10.1016/j.ejon.2007.10.002 Crossref, Medline, Google Scholar
- (2013) Pathobiology of chemotherapy-induced hair loss. Lancet Oncol 14(2): e50-59. doi: https://doi.org/10.1016/S1470-2045(12)70553-3 Crossref, Medline, Google Scholar
Paxman (2016) A better fit: new cold cap crosses launched. http://tinyurl.com/jmcgbul (accessed 16 May 2016 ) Google Scholar- (2015) Familiarity, opinions, experiences and knowledge about scalp cooling: a Dutch survey among breast cancer patients and oncological professionals. Asia Pacific Journal of Oncology Nursing 2(1): 35–41 Crossref, Google Scholar
- (2015) Clinical Performance of the DigniCap System, a Scalp Hypothermia System, in Preventing Chemotherapy Induced Alopecia. J Clin Oncol 33 (suppl; abstr 9518) 2015 American Society of Clinical Oncology, ASCO Annual Meeting. http://tinyurl.com/z55mby5 (
accessed 18 May 2016 ) Google Scholar - (2015) The influence of various parameters on the success of sensor-controlled scalp cooling in preventing chemotherapy-induced alopecia. Oncol Res Treat 38(10): 489–95. doi: https://doi.org/10.1159/000440636 Crossref, Medline, Google Scholar
- (2015) Efficacy of interventions for prevention of chemotherapy-induced alopecia: a systematic review and meta-analysis. Int J Cancer 136(5): E442-454. doi: https://doi.org/10.1002/ijc.29115 Crossref, Medline, Google Scholar
- (2012) Scalp cooling for hair preservation and associated characteristics in 1411 chemotherapy patients—results of the Dutch Scalp Cooling Registry. Acta Oncol 51(4): 497–504. doi: https://doi.org/10.3109/0284186X.2012.658966 Crossref, Medline, Google Scholar
- (2013) Scalp cooling to prevent alopecia after chemotherapy can be considered safe in patients with breast cancer. Breast 22(5): 1001–4. doi: https://doi.org/10.1016/j.breast.2013.07.039 Crossref, Medline, Google Scholar
- (2015) Testing chemotherapeutic agents in the feather follicle identifies a selective blockade of cell proliferation and a key role for sonic hedgehog signaling in chemotherapy-induced tissue damage. J Invest Dermatol 135(3): 690–700. doi: https://doi.org/10.1038/jid.2014.409 Crossref, Medline, Google Scholar
- (2013) Chemotherapy-induced alopecia: a cool to action. Br J Nurs 22(11): 608. doi: https://doi.org/10.12968/bjon.2013.22.11.608 Link, Google Scholar



